BioSpace News Archive

Biotech Bay

OXiGENE Complies With NASDAQ Listing Requirements

June 6, 2011
·
1 min read
BioMidwest

MedPro Imaging Adds 4D Transducer Repair Capabilities

June 6, 2011
·
2 min read
Drug Development

Endocyte, Inc.'s EC145 Meets Primary Endpoint in Phase 2 Study, Demonstrating 85 Percent (2.3 month) Improvement in Median Progression-Free Survival for Treatment of Platinum Resistant Ovarian Cancer

June 6, 2011
·
1 min read
Drug Development

OXiGENE Reports Encouraging Data From Phase 2 Trial of ZYBRESTAT(TM) in Non-small Cell Lung Cancer

June 6, 2011
·
1 min read
Drug Development

Cell Therapeutics, Inc. Release: New Interim Phase II Clinical Data from the OPAL Study Demonstrate Encouraging Single Agent Response Rates for Tosedostat in Elderly Patients with Relapsed Refractory AML

June 6, 2011
·
5 min read
BioMidwest

Acura Pharmaceuticals, Inc. Announces Notice of Allowance for Third Aversion(R) Technology Patent

June 6, 2011
·
1 min read
Drug Development

Raptor Pharmaceutical Inc. Provides Update on Phase 3 Clinical Trial of DR Cysteamine for the Potential Treatment of Nephropathic Cystinosis

June 6, 2011
·
1 min read
Drug Development

Geron Corporation Highlights American Society of Clinical Oncology/American Association for Cancer Research Joint Session: Telomeres and Telomerase in Cancer

June 6, 2011
·
1 min read
Drug Development

Infinity Pharmaceuticals Inc. Reports Results From Phase 1b Clinical Trial of IPI-926, an Oral Smoothened Antagonist, in Pancreatic Cancer at American Society of Clinical Oncology Meeting

June 6, 2011
·
1 min read
Business

Evotec AG and Active Biotech AB Enter Into Medicinal Chemistry Collaboration

June 6, 2011
·
1 min read